Barron\'s - 05.08.2019

(Michael S) #1

August 5, 2019 BARRON’S M7


The Striking Price


Options


It’s Time to Bet on Tech Stocks


By Steven M. Sears


INSTITUTIONAL INVESTORS PRETTY MUCH OWN


allofthesamestocks,yetanotherbankre-


centlynoted.Arealistmightconcludethat


such investors operate expensive index


funds that all buy the same things and


chargehighmanagementfeesfordoingso.


Ifyouwanttogiveyourmoneytothese


guys, go ahead. But that’s probably as ap-


pealing to you as buying stocks that are


dancing around highs.


Manyinvestorsareworriedaboutlofty


valuations and economic uncertainty, and


that has helped create the proverbial wall


ofworrythatdefinesabullmarket.Those


concerns have plumped the premiums of


manydownsideputoptions,whichnervous


investors buy to hedge their equity posi-


tions.(Putsincreaseinvaluewhentheun-


derlying security’s price declines.)


Thatcreatesopportunitiesforinvestors


willing to sell puts.


In a time of heightened nervousness,


downsideputsalmostalwaystradeatafear


premium.Thisiswidelyknownamongmar-


ketinsiders,whooftenrefertosellingputs


on blue-chip stocks—allowing the seller to


pocket a premium if the underlying stock


rises in value, but also committing him or


hertobuythesharesiftheirpricefalls—as


one of the truly great strategies.


Consider Microsoft (ticker: MSFT),


one of the crowded stocks. It’s up 33% this


year, about double the return of the S&P


500 index. The companyrecentlyreported


good earnings, aided by the success of its


Azure cloud-computing business and soft-


ware subscription sales, and its shares


have been hovering around their 52-week


high. During the past year, their price has


ranged from $93.96 to $141.68. Several an-


alysts have targets of $155 to $160.


When Microsoft was around $136, the


October $130 put could be sold for $2.45.


Thispositionsinvestorstobuythestockat


an effective price of $127.55. Should the


stockbeabovethestrikeatexpiration,in-


vestors pocket the put premium. The key


riskisthatthestockcouldplummetfarbe-


low the put strike, obligating the options’


sellerstobuybacktheputformoremoney


than they received for the sale or to buy


the stock for the put strike price, even if


the stock price is lower.


Theapproachworksforanysharesthat


you’dbewillingtobuyatlowerprices,but


isparticularlyappealingfortradingstocks


of major tech companies that now are al-


mostcertainlybeinginvestigatedforanti-


trustviolationsbytheJusticeDepartment.


The probe follows a letter sent to the


Federal Trade Commission by the Retail


IndustryLeadersAssociation,orRILA,in


lateJune.Thetradegrouprepresentsmore


than 200 retailers, including Walmart


(WMT) and Target (TGT).


The association wasn’t complaining


aboutcompetitionfrom Facebook (FB), Al-


phabet (GOOGL), Amazon.com (AMZN),


Visa (V), or any other tech or payments


platform,wroteBrianDodge,RILA’schief


operatingofficer.Instead,hecontended, his


members want a level playing field. He


charges that tech companies influence


prices and even determine what shoppers


see when they are ready to buy.


In the past, we’ve recommended selling


puts on Facebook and buying its stock, an-


ticipatingthatthegovernmentmighttryto


breakupthesocial-mediagiant.Thenewin-


vestigation—even though the DOJ didn’t


name any companies—validates the recom-


mendation. It should solidify the fear pre-


mium in Facebook puts.


Thepressureonbig,crowdedtechstocks


is likely to increase, and that’s good for in-


vestors. Fear is one of the few real friends


anyone has in the financial markets. And


selling puts—especially on dividend stocks


thatareindemandfortheiryields—remains


oneofthebestwaysthatwell-heeledinves-


tors,whocanwarehousequalitystocks,can


take advantage of the market mob.


The higher stock prices go, the edgier


investors will become. Should a great


shakeoutoccur,manyputpriceswillfurther


inflate, with even richer fear premiums,


creating even greater opportunities.


email: [email protected]


Equity Options


CBOE VOLATILITY INDEX


VIX Close VIX Futures

10


15


20


25


30


35


40


SO NDJ FMAM J J A

Daily Values Source: CBOE

THE EQUITY-ONLY PUT-CALL RATIO


Put-Call Ratio S&P 500 Index

50


80


110


140


170


200


230


260


SO NDJ FMAM J J A

Source: McMillan Analysis Corp.

SPX SKEW


Implied volatility %

7


8


9


10


11


12


13%


SO NDJ FMAM J J A

Source: Credit Suisse Equity Derivatives Strategy

NDX SKEW


Implied volatility %

8


9


10


11%


SO NDJ FMAM J J A

Source: Credit Suisse Equity Derivatives Strategy

Skew indicates whether the options market expects a stock-market advance or decline. It measures the difference
between the implied volatility of puts and calls that are 10% out of the money and expire in three months. Higher
readings are bearish.

Week'sMostActive


Company Symbol TotVol Calls Puts AvgTotVol IV%ile Ratio

Ferro FOE 6252 5766 486 256 84 24.4


Harsco HSC 17992 137 17855 864 9 20.8


2U TWOU 35360 22540 12820 1724 100 20.5


Now DNOW 7010 5915 1095 512 91 13.7


SS&C Technologies SSNC 33377 17504 15873 2552 76 13.1


Trex Company TREX 16138 12402 3736 1232 44 13.1


Smith & Nephew SNN 6881 6783 98 540 22 12.7


Lexicon Pharm LXRX 10410 9227 1183 992 99 10.5


Medpace Holdings MEDP 8280 3605 4675 836 13 9.9


Unisys UIS 15035 13611 1424 1836 12 8.2


Delphi Technologies DLPH 26435 14036 12399 3300 81 8.0


Antero Midstream AM 28526 17552 10974 3592 98 7.9


STAAR Surgical STAA 31609 20897 10712 4108 60 7.7


Concho Resources CXO 85494 33842 51652 11828 95 7.2


Gannett GCI 16644 15797 847 2304 52 7.2


Post Holdings POST 5892 1485 4407 848 88 6.9


Waters WAT 10330 2843 7487 1544 57 6.7


Gartner IT 9320 6213 3107 1444 75 6.5


Beryl Drugs BERY 31619 18012 13607 4968 69 6.4


CyrusOne CONE 38296 36619 1677 5948 77 6.4


Thistableofthemostactiveoptionsthisweek,ascomparedto average weeklyactivity–notjustrawvolume.Theideaisthatthe
unusuallyheavytradingintheseoptionsmightbeapredictorofcorporateactivity–takeovers,earningssurprises,earningspre-
announcements,biotechFDAhearingsordrugtrialresultannouncements,andsoforth.Dividendarbitragehasbeeneliminated.In
short,thislistattemptstoidentifywhereheavyspeculationistakingplace. Theseoptionsarelikelytobeexpensiveincomparisonto
theirusualpricinglevels.Furthermore,manyofthesesituationsmayberumor-driven.Mostrumorsdonotprovetobetrue,soone
shouldbeawareoftheseincreasedrisksiftradinginthesenames
RatioistheTotVoldividedbyAvgTotVol.IV%ileishowexpensivetheoptionsareonascalefrom0to100.

Source:McMillanAnalysis

Free download pdf